IP Archives of Cytology and Histopathology Research
Official Publication of Khyati Education and Research Foundation
Official Publication of Khyati Education and Research Foundation
Print ISSN: 2581-5725
Online ISSN: 2456-9267
CODEN : IACHCL
IP Archives of Cytology and Histopathology Research (ACHR) open access, peer-reviewed quarterly journal publishing since 2016 and is published under the Khyati Education and Research Foundation (KERF), is registered as a non-profit society (under the society registration act, 1860), Government of India with the vision of various accredited vocational courses in healthcare, education, paramedical, yoga, publication, teaching and research activity, with the aim of faster and better dissemination of knowledge, we will be publishing the article more...Case Report
Author Details :
Volume : 8, Issue : 1, Year : 2023
Article Page : 56-59
https://doi.org/10.18231/j.achr.2023.013
Abstract
Leiomyosarcoma is the malignant counterpart of leiomyoma. It arises from smooth muscle of the uterus and is rare tumor that account for 2-5% of all uterine malignancy. We report a case of 60 years old female who presented with post menopausal bleeding with endometrial polyp. A total abdominal hysterectomy specimen was received in our center. A differential diagnosis of leiomyosarcoma/ Endometrial stromal sarcoma was made by histopathological examination. Immunohistochemistry report confirmed the diagnosis of uterine Leiomyosarcoma.
Keywords: Leiomyosarcoma, Postmenopausal bleeding, Endometrial polyp, Immunohistochemistry
How to cite : Khan S N, Patidar E, Hawaldar R, Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and leiomyosarcoma in an endometrial polyp: A case report. IP Arch Cytol Histopathol Res 2023;8(1):56-59
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
